Biktarvy
Generic: bictegravir/emtricitabine/tenofovir
Manufacturer: Gilead · Program: Gilead Advancing Access Patient Assistance Program
Apply for AssistanceEligibility Criteria
Insurance Requirement
Uninsured, underinsured, or Medicare Part D patients who meet the financial eligibility criteria and lack alternative coverage.
Residency
U.S. resident or resident of U.S. territories with a valid address
Income Threshold
Up to 500% FPL
Individual Income Limit
$75,300/year
Income limit is 500% of the 2025 FPL guidelines.
Program Information
Processing Time
1-2 business days
Delivery Method
shipped to patient
Application Method
Multiple
Reauthorization
Required — annual
Typically Required Documents
ProvisionRX prepares and organizes all required documentation as part of your enrollment management. This list is provided for informational purposes.
- Proof of income (e.g., most recent tax return, W-2, or pay stubs)
- Signed patient and prescriber application form
- Valid prescription
Indicated For
HIV-1 infection
About This Medication
# A Patient's Guide to Getting Biktarvy Through the Gilead Advancing Access Patient Assistance Program --- ## Who Qualifies for the Gilead Advancing Access Patient Assistance Program? If you have been prescribed Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) for HIV-1 infection and cannot afford it, the **Gilead Advancing Access Patient Assistance Program** may be able to help you get it at little or no cost. For a household of one person, your annual income must be at or below **$75,300** to meet the financial eligibility threshold. In terms of insurance, this program is designed for people who are uninsured, underinsured, or enrolled in Medicare Part D — and who do not have other coverage that adequately pays for Biktarvy. If you meet those basic conditions, you may qualify to receive your medication shipped directly to your home at no charge. --- ## About Biktarvy (bictegravir/emtricitabine/tenofovir) Biktarvy is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat HIV-1 infection in adults and certain pediatric patients. It combines three active ingredients — bictegravir, emtricitabine, and tenofovir alafenamide — into a single daily tablet. Biktarvy belongs to two drug classes: Integrase Strand Transfer Inhibitors (INSTIs) and Nucleoside Reverse Transcriptase Inhibitors (NRTIs). Without insurance or assistance, Biktarvy can cost several thousand dollars per month, making it financially out of reach for many patients. The Gilead Advancing Access Patient Assistance Program exists specifically to help eligible patients access this medication when cost would otherwise be a barrier. --- ## Income Eligibility: Full Breakdown Gilead sets income limits at **500% of the 2025 Federal Poverty Level (FPL)**. The table below shows the maximum annual income allowed based on your household size: | Household Size | Maximum Annual Income | |---|---| | 1 person | $75,300 | | 2 persons | $102,200 | | 3 persons | $129,100 | | 4 persons | $156,000 | Your household size includes everyone living with you who shares finances, such as a spouse, partner, or dependents. If your household is larger than four people, the income limit continues to increase — contact Gilead directly at **(800) 226-2056** to ask about your specific situation. To verify your income, Gilead typically requires your most recent federal tax return, a W-2 form, or three months of recent pay stubs. If your income has changed significantly since your last tax filing — for example, due to job loss — you may be able to use current pay stubs instead of your tax return to better reflect your actual situation. If your income is above these limits, you will not qualify for the patient assistance program, but you may still have other options. See the "Alternatives If You Don't Qualify" section below for next steps. --- ## Insurance Requirements Explained Your insurance situation plays an important role in whether you qualify. Here is how different coverage types are handled: - **If you are uninsured:** You are a strong candidate for this program. Gilead designed it specifically to serve people without any drug coverage, and you may qualify based on income alone. - **If you have Medicare Part D:** You may still be eligible. Unlike many manufacturer assistance programs that exclude Medicare Part D patients entirely, the Gilead Advancing Access Patient Assistance Program does have provisions for Medicare Part D enrollees who meet the financial criteria and lack other adequate coverage. - **If you have private insurance that covers less than 50% of the cost:** You may qualify as an "underinsured" patient. If your out-of-pocket costs remain unaffordable after your insurance pays, you may be eligible for assistance. - **If you have Medicaid:** Patients with full Medicaid coverage that includes Biktarvy are generally not eligible, because Medicaid is considered adequate coverage for program purposes. --- ## Step-by-Step: How to Apply Follow these steps to apply for the Gilead Advancing Access Patient Assistance Program: 1. **Gather your documents before you start.** You will need: proof of income (your most recent tax return, W-2, or three months of pay stubs), a valid prescription for Biktarvy from your prescriber, and a completed application form signed by both you and your prescriber. 2. **Choose your application method.** You can apply online, by phone, or by fax: - **Online:** Visit [https://www.gileadadvancingaccess.com/](https://www.gileadadvancingaccess.com/) to start your application through their secure portal. - **Phone:** Call **(800) 226-2056** to speak with a program representative who can guide you through the process. - **Fax:** Complete a paper application and fax it to **(800) 216-0153**. 3. **Complete the application form.** Both you and your doctor must sign the form. Your prescriber's office can often help with this step, so do not hesitate to ask them. 4. **Submit all documents together.** Incomplete applications may be delayed, so make sure your income documentation and signed forms are included with your submission. 5. **Wait for a decision.** Processing typically takes **1 to 2 business days** after Gilead receives a complete application. 6. **Receive your approval notice.** Once approved, Gilead will confirm your eligibility and arrange shipment of your medication. --- ## What to Expect: Timeline and Delivery Once Gilead receives your complete application, a decision typically comes within **1 to 2 business days**. Gilead or their pharmacy partner will contact you — and in some cases your prescriber — to confirm approval. If approved, your Biktarvy will be **shipped directly to your home address**, so you do not need to pick it up at a pharmacy or take any additional steps at a separate location. Your approval is valid for one year. Before that period ends, you will need to **reauthorize your enrollment** by submitting updated income documentation and a renewed prescription. Watch for renewal reminders from Gilead so your medication supply is not interrupted. --- ## Alternatives If You Don't Qualify If you do not meet the income or insurance requirements for this program, you still have options: 1. **Biosimilars:** There are currently **no FDA-approved biosimilar alternatives** to Biktarvy, so this option is not available at this time. 2. **Manufacturer savings card for insured patients:** If you have commercial insurance, Gilead offers a separate copay assistance card that may reduce your out-of-pocket costs significantly. You can learn more and enroll at [https://www.gileadadvancingaccess.com/copay-card](https://www.gileadadvancingaccess.com/copay-card). 3. **State Pharmaceutical Assistance Programs (SPAPs):** Many states run their own programs to help residents afford prescription drugs. Eligibility and benefits vary by state. Contact your state's department of health or aging to ask what programs may be available to you. 4. **NeedyMeds.org:** This free online database at [https://www.needymeds.org](https://www.needymeds.org) lists hundreds of patient assistance programs, disease-specific funds, and other resources. It is a helpful starting point if you are exploring all available options. --- > *This guide is for informational purposes only and does not constitute medical or legal advice. Eligibility determinations are made solely by Gilead. Program terms may change — verify current requirements at [https://www.gileadadvancingaccess.com/copay-assistance/patient-assistance-program](https://www.gileadadvancingaccess.com/copay-assistance/patient-assistance-program) before applying.* ---
Program information last verified: February 27, 2026
Ready to apply for Biktarvy assistance?
ProvisionRX manages the complete application process. Start your application in about 15 minutes.